A recently published report from the European Centre for Disease Prevention and Control (ECDC) discussed an assessment mission in 2018 on antimicrobial resistance (AMR) issues in Norway.
The overall objective of the mission was to provide an observation-based assessment of the situation in Norway regarding prevention and control of AMR through prudent use of antibiotics and infection control.
Data showed that the proportion of AMR in bacteria from bloodstream infections in Norwegian patients is consistently below the EU/EEA average and often among the lowest in Europe. Nevertheless, resistance to broad-spectrum antibiotics such as third-generation cephalosporins has been increasing over the past ten years. This is the result of emergence of strains that produce an extended-spectrum beta-lactamase (ESBL), combined with increasing consumption of broad-spectrum antibiotics in healthcare.
The report can be viewed on the ECDC website.
Source: ECDC, 16 January 2019